Comment on: “Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(T)ide Analogues”: The Critical Need to Assess Serial Score Changes for Dynamic Risk Stratification
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Hepatitis B Virus Studies
Liver Disease and Transplantation
Publication details
- Journal / source
- Journal of Gastroenterology and Hepatology
- Volume
- 41
- Issue
- 4
- Pages
- 1374–1375
- Publication date
- 6 March 2026
- Language
- EN